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Sirtuins are thought to form crucial links between energy levels and cellular metabolism. Libert et al.
now provide evidence that SIRT1 activity in the brain modifies mammalian emotional behavior
via monoamine signaling and that changes in this pathway might contribute to human affective
disordersCharles Darwin intended to include a
chapter on emotions, their function, and
their evolution in his book The Descent of
Man, but in the end he found the subject
so rich and so important that The
Expression of the Emotions in Man and
Animals became an entire book. Ever
since, science has been trying to unravel
the adaptive significance of behavioral
states and emotions, what neural sub-
strates underlie them, and how they go
awry in human psychiatric conditions.
In this issue of Cell, Libert et al. (2011)
tackle all three of these questions in
proposing that the metabolically regu-
lated enzyme sirtuin 1 (SIRT1) modulates
monoamine oxidase A (MAO-A) levels
to link mood and behavior to energy
consumption. Moreover, they provide
evidence that variability in the SIRT1
gene contributes to human susceptibility
to anxiety disorders.
MAO-A is the brain’s primary means of
degrading serotonin and noradrenaline
and has been a focus of mood disorder
research ever since the serendipitous
1952 discovery that inhibiting it has anti-
depressant effects. MAO inhibitors were
the first widely used and effective phar-
macotherapy for depression and some
anxiety disorders.
Currently there is much excitement
about drugs that modulate sirtuins.
Research on these enzymes has grown
explosively, and often controversially,
over the last decade since theywere found
to mediate, at least in part, the longevity-
enhancing effects of caloric restriction in1436 Cell 147, December 23, 2011 ª2011 Elsbudding yeast. As sirtuin homologs are
conserved from bacteria to mammals,
and caloric restriction extends life span
in higher animals, there is considerable
interest in the possibility that sirtuin acti-
vation might thwart numerous diseases
and prolong human life.
The overarching hypothesis of sirtuin
function is that their activity matches
cellular physiology to energy availability
(Guarente, 2000; Canto´ and Auwerx,
2009). Sirtuins are primarily NAD+-depen-
dent deacetylases, although among the
seven mammalian isoforms, some have
ADP-ribosyl transferase activity. Much
work in yeast focuses on histone deacety-
lation, but a diverse range of sirtuin
substrates has now been identified (Mi-
chan and Sinclair, 2007). Sirtuin activity is
typically inversely related to caloric intake,
and it is thought that this is due tometabol-
ically induced variation in NAD+:NADH
ratios, although caloric restriction often
also increases sirtuin expression levels.
Given that in animals, behavior is central
to adapting to environmental resource
levels, the idea that sirtuins might impact
neural function is attractive.
Libert et al. tested two strains of mice in
assays that measure aspects of affective
behavior. Mice lacking SIRT1 expression
in the brain spent more time exploring an
open space, indicative of lower anxiety
levels; struggled more in the forced
swim test, suggesting greater stress resil-
ience; and appeared protected against
the anhedonic effects of social defeat.
Conversely, mice globally overexpressingevier Inc.SIRT1 had higher anxiety scores than
controls. In these mice, chronic treatment
with an MAO inhibitor, which reduces
anxiety, normalized behavioral scores
across genotypes.
When the authors tested whole brain
monoamine levels, they found that anxiety
scores were negatively correlated with
changes in serotonin and noradrenaline
levels. HowSIRT1 affects these neuromo-
dulators was revealed through elegant
and systematic in vivo and in vitro ex-
perimentation, which showed that SIRT1
deacetylates the transcription factor
NHLH2 to control MAO-A expression.
The study concludes with tests of the
psychiatric relevance of this pathway and
a model for its evolution. SIRT1 polymor-
phism frequencies were measured across
control and psychiatric patient popula-
tions, and both rare and common alleles
were associated with anxiety-related
disorders, consistent with a previous
linkage with depression (see Libert
et al., 2011, references therein). In vitro
assays of two variant alleles showed
them to have increased SIRT1 activity.
The evolutionary considerations are
more speculative; a dynamic model of a
three-tier food chain predicts that the
middle species will experience greatest
predation when food is scarcest. Finding
that calorie-restricted mice show a mod-
erate decrease in exploratory behavior,
the authors suggest that SIRT1 signaling
adaptively controls behavior so that
hungry, heavily preyed-on animals would
be best served by being anxious, vigilant,
Figure 1. A Pathway for Linking Caloric Intake to Anxiety Levels
Decreased calorie consumption increases SIRT1 levels and activity, which
leads to greater NHLH2 deacetylation and increased MAO-A expression.
Elevated MAO-A levels decrease serotonin (5-HT) and noradrenaline
concentrations in the brain and promote anxious behavior. The other factors
that control SIRT1 activity and how the modification of other SIRT1 substrates
affect behavior, and possibly life span, remain to be determined.and careful, whereas well-fed
mice should carelessly radiate
and procreate.
At the end of this paper, you
feel the need for a deep
breath, so wide-ranging and
provocative are its contents.
Its predictions are so specific
and testable and the ques-
tions it raises so interesting
and numerous that it will be
a touchstone for the certain
expansion of neurobiological
studies of sirtuin function (Fig-
ure 1). These enzymes have
already been implicated in
synaptic plasticity and cog-
nition (Gao et al., 2010), hypo-
thalamic control of energy
intake (Satoh et al., 2010),
and responses to cocaine
(Renthal et al., 2009).
Among the most important
questions raised by the cur-
rent study is whether regula-
tion of MAO-A levels is the
sole route by which SIRT1
impacts brain function. The
normalization of behavioral
scores by MAO inhibitors isREFERENCEsupportive but by no means conclusive,
and the relationship between monoamine
levels and behavior is complex. For
example, depleting serotonin levels in
healthy humans does not evoke mood
changes. Given the multitude of SIRT1
substrates now identified, it will be essen-
tial to test whether other signaling path-
ways are involved and whether altered
synaptic plasticity contributes to behav-
ioral changes (Michan and Sinclair,
2007; Gao et al., 2010).
At the systems level, SIRT1 is found at
moderate levels throughout the brain,
and determining through which structures
it acts to modulate which aspects of
behavior, and if it always operates via
the same pathways, will be fascinating.
Conversely, elucidating whether factors
other than caloric intake, such as neuronal
activity or neuromodulatory signaling cas-
cades, regulate sirtuin activity will be
crucial. And does SIRT1 act distinctly at
different developmental stages? Interest-
ingly, NHLH2 is most abundant in the
embryonic brain.Tying anxiety levels conclusively to
caloric intake will also take more work,
and the decreased exploratory drive of
calorie-restricted mice needs to be linked
directly to sirtuin signaling. In terms of
human relevance, one wonders whether
the growing number of people adopting
calorie-restricted diets might allow fur-
ther testing of these hypotheses. The
evolutionary model is appealing, but the
dynamics of behavioral responses to
food deprivation are complex (Wang
et al., 2006); vigilance and fearfulness
must be balanced with action and oppor-
tunity taking. Whether a straightforward
relationship between food availability and
anxiety isoptimal remains tobeconfirmed.
Finally, the authors emphasize that their
findings make SIRT1 inhibitors excellent
candidate anxiolytic drugs. This idea is
certainly testable, and we look forward
to seeing the results. However, given
that activating sirtuins has been sug-
gested for treating or preventing aging,
diabetes, cardiovascular disease, some
forms of cancer, and Alzheimer’s disease,Cell 147, December 23,not to mention sirtuins’ pro-
posed role in learning, the
pharmacology is likely to be
challenging (Kaeberlein,
2008). MAO inhibitors fell out
of favor not because they
lacked clinical efficacy but
because of side effects and
safety issues.
Sirtuin research in the
central nervous system is
certain to grow rapidly in
the coming years. Given the
brain’s complexity and the
current controversies in thesir-
tuin field—including whether
NAD+:NADH balance is the
principal controller of activity
(Canto´ and Auwerx, 2009)
and whether the life-extending
effects of sirtuin homologs
previously observed in nema-
todes and fruit flies were due
to genetic background effects
(Burnett et al., 2011)—it’s
sure to be an engrossing
time. One can bet that this
work will be but one chapter
in a very long book.
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